Filter
114
Filtered Results: 114
Text search:
S.
Swaminathan
Featured
Recommendations
13
New Publications
15
Language
Document type
No document type
64
Studies & Reports
16
Videos
12
Guidelines
10
Manuals
6
Fact sheets
3
Resource Platforms
2
Infographics
1
Countries / Regions
India
31
Kenya
3
Brazil
3
Nepal
2
China
2
Mozambique
2
Global
2
Asia
2
Latin America and the Carribbean
2
Middle East and North Africa
2
South–East Asia Region
2
Russia
2
Angola
2
Indonesia
2
North Korea
1
Colombia
1
Timor Leste/ East Timor
1
Thailand
1
Ukraine
1
Syria
1
Nigeria
1
Malawi
1
Malaysia
1
Guinea-Bissau
1
Tanzania
1
West and Central Africa
1
Japan
1
Portugal
1
Spain
1
East and Southern Africa
1
Bangladesh
1
South Africa
1
Vietnam
1
Eastern Europe
1
Sri Lanka
1
Ethiopia
1
Bhutan
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
38
Clinical Guidelines
13
Public Health
5
Key Resources
2
Women & Child Health
1
Toolboxes
COVID-19
26
TB
25
HIV
8
NTDs
5
Planetary Health
3
Ebola & Marburg
2
Caregiver
2
NCDs
2
AMR
2
Mental Health
1
Refugee
1
Natural Hazards
1
Health Financing Toolbox
1
Global Health Education
1
TB heroes
Hello, my name is Nurse X
My job is to promote integrated HIV and TB prevention, care, treatment and support. This ensures that we, and my team of health care service providers treat everyone who is living with HIV and TB to have all the antiretroviral therapy (ART) and HIV care services...
These guidelines have been developed specifically to address ethical issues of conducting research in children.
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Цель настоящего документа («Основные положения») заключается в подготовке рекомендаций относительно необходимых на национальном уровне мер по адаптации стратег...
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...
Division of Noncommunicable Diseases | draft guidelines on diagnosis and management of a chronic immune-mediated enteropathy called celiac disease. This disease is caused is mainly caused in genetically susceptible individuals by ingestion of gluten proteins that are present in wheat, barley and oat...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health research and patient treatment. As the use of laboratory...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе ...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
